Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
45.08
+0.75 (1.69%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Agios Pharmaceuticals Employees
As of December 31, 2023, Agios Pharmaceuticals had 386 total employees, including 383 full-time and 3 part-time employees. The number of employees decreased by 7 or -1.78% compared to the previous year.
Employees
386
Change (1Y)
-7
Growth (1Y)
-1.78%
Revenue / Employee
$81,104
Profits / Employee
-$945,417
Market Cap
2.56B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Amneal Pharmaceuticals | 7,700 |
QuidelOrtho | 7,100 |
Evolent Health | 4,700 |
Inari Medical | 1,300 |
Twist Bioscience | 919 |
GoodRx Holdings | 694 |
Arrowhead Pharmaceuticals | 525 |
Catalyst Pharmaceuticals | 167 |
AGIO News
- 7 days ago - Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024 - GlobeNewsWire
- 6 weeks ago - Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) - GlobeNewsWire
- 7 weeks ago - Agios to Present at the 2024 Cantor Global Healthcare Conference on September 18, 2024 - GlobeNewsWire
- 2 months ago - Agios' Mitapivat: A Potential Blockbuster In Thalassemia Treatment - Seeking Alpha
- 2 months ago - Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib - GlobeNewsWire
- 3 months ago - Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides - Benzinga
- 3 months ago - Agios Pharmaceuticals, Inc. (AGIO) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Agios Reports Business Highlights and Second Quarter 2024 Financial Results - GlobeNewsWire